Table 2.

Efficacy of increased doses of non-sedating antihistamines in patients with chronic urticaria

			Efficacy
Author ref	Drug	Dose (mg)	Responders/n	%
Finn [17]	Fexofenadine	120 BD	46/89	51.6
Finn [17]	Fexofenadine	240 BD	54/83	64.9
Nelson [18]	Fexofenadine	120 BD	33/77	42.8
Nelson [18]	Fexofenadine	240 BD	46/82	56.0
Giménez-Arnau [19]	Rupatadine	20 QD	69/109	63.3
Dubertret [20]	Rupatadine	20 QD	48/67	71.6
Siebenhaar [21]	Desloratadine	20 QD	15/30	50.0
Staevska [22]	Desloratadine	10 QD	7/36	19.4
Staevska [22]	Desloratadine	20 QD	1/29	3.4
Staevska [22]	Levocetirizine	10 QD	8/31	25.8
Staevska [22]	Levocetirizine	20 QD	5/23	21.7
Krause [23]	Bilastine	40 QD	11/20	55.0
Krause [23]	Bilastine	80 QD	12/20	60.0